CSIMarket Company Name, Ticker, Suppliers, else..
 
Applied Genetic Technologies Corporation  (NASDAQ: AGTC)
 

AGTC's Market share relative to its competitors, as of Q1 2022

As of Q1 2022 (Revenue in Millions of $)

Date modified: 2026-05-18T22:42:44+00:00




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

COMPANY NAME REVENUES
12 Months Ending
Q1 2022		 MARKET SHARE
12 Months
Q1 2022		 MARKET SHARE
MRQ
Q1 2022		 MARKET SHARE
A Quarter Before
Q4 2021
Applied Genetic Technologies Corporation 41.69 0.00% 0.00 % 0.29 %
Bluebird Bio Inc 103.95 0.00% 16.05% 33.78%
4d Molecular Therapeutics Inc 88.24 0.00% 1.57% 2.67%
Regenxbio Inc 87.82 0.00% 44.79% 5.61%
Protalix Biotherapeutics inc 76.38 0.00% 8.25% 29.60%
Voyager Therapeutics Inc 50.75 0.00% 1.31% 2.27%
16 more competitors available

Sign in to see all competitors for Applied Genetic Technologies Corporation.

Sign In Create Free Account



AGTC's Market share relative to its competitors, as of Q1 2022 within the Biotechnology & Pharmaceuticals Industry
As of Q1 2022



COMPANY NAME MARKET SHARE
12 Months Ending
Q1 2022		 MARKET SHARE
12 Months Ending
Q4 2021		 MARKET SHARE
MRQ
Q1 2022		 MARKET SHARE

Q4 2021
Applied Genetic Technologies Corporation 7.09% 7.18% 0.00 % 0.29 %
Bluebird Bio Inc 17.66% 12.89% 18.65% 33.78%
4d Molecular Therapeutics Inc 15.00% 13.10% 1.82% 2.67%
Regenxbio Inc 14.92% 26.21% 52.04% 5.61%
Protalix Biotherapeutics inc 12.98% 8.11% 9.58% 29.60%
Voyager Therapeutics Inc 8.62% 10.30% 1.52% 2.27%
13 more companies available

Sign in to see all industry competitors for Applied Genetic Technologies Corporation.

Sign In Create Free Account



AGTC's Market share relative to its competitors, as of Q1 2022 within the Healthcare Sector
As of Q1 2022



COMPANY NAME MARKET SHARE
12 Months Ending
Q1 2022		 MARKET SHARE
12 Months Ending
Q4 2021		 MARKET SHARE
MRQ
Q1 2022		 MARKET SHARE

Q4 2021
Applied Genetic Technologies Corporation 0.00% 1.27% 0.00 % 0.29 %
Bluebird Bio Inc 0.00% 2.29% 18.65% 33.78%
4d Molecular Therapeutics Inc 0.00% 2.32% 1.82% 2.67%
Regenxbio Inc 0.00% 4.65% 52.04% 5.61%
Protalix Biotherapeutics inc 0.00% 1.44% 9.58% 29.60%
Voyager Therapeutics Inc 0.00% 1.83% 1.52% 2.27%
15 more companies available

Sign in to see all sector competitors for Applied Genetic Technologies Corporation.

Sign In Create Free Account



Note: Market share is calculated based on total revenue. To get a more accurate picture of Applied Genetic Technologies Corporation's market divisions, geographic dispersion, segments, products, and services, visit Applied Genetic Technologies Corporation's Business Segment.

The list includes publicly traded companies only. More information about the sources of this report can be found here.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.